733 reports of this reaction
3.9% of all ICOSAPENT ETHYL reports
#2 most reported adverse reaction
PRODUCT PHYSICAL ISSUE is the #2 most commonly reported adverse reaction for ICOSAPENT ETHYL, manufactured by Amarin Pharma Inc.. There are 733 FDA adverse event reports linking ICOSAPENT ETHYL to PRODUCT PHYSICAL ISSUE. This represents approximately 3.9% of all 18,725 adverse event reports for this drug.
Patients taking ICOSAPENT ETHYL who experience product physical issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT PHYSICAL ISSUE is moderately reported among ICOSAPENT ETHYL users, representing a notable but not dominant share of adverse events.
In addition to product physical issue, the following adverse reactions have been reported for ICOSAPENT ETHYL:
The following drugs have also been linked to product physical issue in FDA adverse event reports:
PRODUCT PHYSICAL ISSUE has been reported as an adverse event in 733 FDA reports for ICOSAPENT ETHYL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT PHYSICAL ISSUE accounts for approximately 3.9% of all adverse event reports for ICOSAPENT ETHYL, making it one of the most commonly reported side effect.
If you experience product physical issue while taking ICOSAPENT ETHYL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.